Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 15/20 | 0.76 |
| ▸ | ABL1 | P00519 | 6/20 | 0.76 |
| ▸ | SRC | P12931 | 5/20 | 0.76 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.76 |
| ▸ | EGFR | P00533 | 3/20 | 0.76 |
| ▸ | FYN | P06241 | 3/20 | 0.76 |
| ▸ | YES1 | P07947 | 3/20 | 0.76 |
| ▸ | LYN | P07948 | 3/20 | 0.76 |
| ▸ | HCK | P08631 | 3/20 | 0.76 |
| ▸ | KIT | P10721 | 3/20 | 0.76 |
| ▸ | BCR | P11274 | 3/20 | 0.76 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.76 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.76 |
| ▸ | FGR | P09769 | 2/20 | 0.76 |
| ▸ | JAK3 | P52333 | 2/20 | 0.76 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.76 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.76 |
| ▸ | SIK1 | P57059 | 2/20 | 0.61 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.61 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1146860 | 0.95 | LCK (0.85) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL29355730 | 0.95 | LCK (0.85) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL20633284 | 0.92 | LCK (0.76) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL4233014 | 0.91 | LCK (0.76) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL4463117 | 0.91 | LCK (0.68) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL27818091 | 0.91 | LCK (0.67) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL15846624 | 0.91 | LCK (0.67) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL30152047 | 0.89 | ABL1 (0.77) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL21495196 | 0.89 | ABL1 (0.77) | LCKABL1SRCMAPK14EGFR | |
| SCHEMBL4462679 | 0.89 | LCK (0.64) | LCKABL1SRCMAPK14EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2960341-B1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | MOLECULAR HEALTH GMBH (DE) | 2018-06-27 | — | — | EP | disclosed |
| EP-3263717-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | Molecular Health GmbH (DE) | 2018-01-03 | — | — | EP | disclosed |
| US-20170315128-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | MOLECULAR HEALTH GMBH (DE) | 2017-11-02 | — | — | US | disclosed |
| EP-2435581-B1 | METHODS OF USE OF A NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) | MOLECULAR HEALTH GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-2960341-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | Molecular Health GmbH (DE) | 2015-12-30 | — | — | EP | disclosed |
| EP-2492355-B1 | Tissue protective erythropoietin receptor (nepor) and methods of use | MOLECULAR HEALTH GMBH (DE) | 2015-04-08 | — | — | EP | disclosed |
| US-20140296318-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | MOLECULAR HEALTH GMBH (DE) | 2014-10-02 | — | — | US | disclosed |
| US-8357501-B2 | Tissue protective erythropoietin receptor (NEPOR) and methods of use | MOLECULAR HEALTH GMBH (DE) | 2013-01-22 | — | — | US | disclosed |
| EP-2109690-B9 | EPH-B4 SPECIFIC SIRNA FOR REDUCING EPO-INDUCED TUMOR CELL GROWTH DURING ANEMIA TREATMENT IN CANCER PATIENTS, TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE. | MOLECULAR HEALTH GMBH (DE) | 2012-10-24 | — | — | EP | disclosed |
| US-20120245087-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | ALEPOR GMBH & CO. KG | 2012-09-27 | — | — | US | disclosed |
| EP-2492355-A1 | Tissue protective erythropoietin receptor (nepor) and methods of use | Life Biosystems GmbH (DE) | 2012-08-29 | — | — | EP | disclosed |
| EP-2109690-B1 | EPH-B4 SPECIFIC SIRNA FOR REDUCING EPO-INDUCED TUMOR CELL GROWTH DURING ANEMIA TREATMENT IN CANCER PATIENTS, TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE. | MOLECULAR HEALTH GMBH (DE) | 2012-04-18 | — | — | EP | disclosed |
| EP-2435581-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | MOLECULAR HEALTH GmbH (DE) | 2012-04-04 | — | — | EP | disclosed |
| WO-2010136192-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | ALEPOR GMBH & CO. KG (DE) | 2010-12-02 | — | — | WO | disclosed |
| US-20090306186-A1 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | ALEPOR GMBH & CO. KG | 2009-12-10 | — | — | US | disclosed |